Our mailing address is:
InVivo Therapeutics Corp.
One Kendall Square, Building 1400 West, Floor 4, Suite B14402
Cambridge, MA 02139
Our Common Stock is listed on the Nasdaq Capital Market (Nasdaq:NVIV).
The CUSIP number for InVivo’s common stock is CUSIP 46186M 506/ISIN US46186M5067.
InVivo Therapeutics Holdings Corp. is registered with the U.S. Security and Exchange Commission and incorporated in the state of Nevada.
InVivo’s independent auditors are RSM US LLP, serving InVivo since 2015.
InVivo’s outside legal counsel is Wilmer Cutler Pickering Hale and Dorr LLP, Boston, Massachusetts, and Ballard Spahr LLP, Las Vegas, Nevada.
The transfer agent and registrar for our common stock is Continental Stock Transfer & Trust Company.